A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia
Clinical trial NCT00253136 · COMPLETED
Trial details
- NCT number
- NCT00253136
- Sponsor
- Janssen, LP
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-11-01
- Enrollment
- 458
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.